Staidson (Beijing) Biopharmaceuticals Co., Ltd. (300204)
Market Open
15 Oct, 07:00 AM
XSHE XSHE Primary ¥
19. 27
-0.52
-2.6276%
¥
13.63B Market Cap
- P/E Ratio
2.67% Div Yield
12.4M Volume
- Eps
¥ 19.79
Previous Close Want to track 300204 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Staidson (Beijing) Biopharmaceuticals Co., Ltd. (300204) Statistics
Valuation metrics
Market Cap 13.63B
Enterprise value 9.39B
Trailing P/E (ttm) -111.31
Forward P/E -
PEG ratio -4.62
Price/Sales (ttm) 49.97
Price/Book (mrq) 12.23
Enterprise Value/Revenue 50.1
Enterprise Value/EBITDA -145.39
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 17.51M
Average volume (90 days) 26.92M
Price summary
52-Week low 18.98
52-Week high 42.65
Beta -
50-Day moving average 20.66
200-Day moving average 24.34
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0
Dividend Date -
Ex-Dividend Date -
Last split factor 13:10
Last split Date 5 May 2016
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.48%
Operating margin -0.49%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.26
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 1.73%
Book value per share (mrq) 1.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
